141 related articles for article (PubMed ID: 12814463)
1. The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.
Lee DK; Haggart K; Currie GP; Anderson SD; Lipworth BJ
Br J Clin Pharmacol; 2003 Jun; 55(6):639-42. PubMed ID: 12814463
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
5. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
6. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
7. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
8. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
Saengpanich S; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
11. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges.
Currie GP; Haggart K; Lee DK; Fowler SJ; Wilson AM; Brannan JD; Anderson SD; Lipworth BJ
Clin Exp Allergy; 2003 Jun; 33(6):783-8. PubMed ID: 12801313
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
Day JH; Briscoe MP; Ratz JD; Danzig M; Yao R
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):328-38. PubMed ID: 19441605
[TBL] [Abstract][Full Text] [Related]
13. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
14. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
15. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
[TBL] [Abstract][Full Text] [Related]
17. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
Goh BS; Ismail MI; Husain S
J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
[TBL] [Abstract][Full Text] [Related]
19. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
20. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
